Innogen is a China-based biopharmaceutical company that develops and commercializes novel drugs for the treatment of diabetes, cardiovascular, and CNS diseases.
Business Model:
Revenue: $5M
Employees: 11-50
Address: No. 720, Cailun Road
City: Zhangjiang
State: shanghai municipality
Zip: 321300
Country: CN
Innogen is a China-based biopharmaceutical company that develops and commercializes novel drugs for the treatment of diabetes, cardiovascular, and CNS diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2021 | Seed | - | 12/2021 | Series A | $0 |
China Everbright Investment Management China Growth Capital | CGC CICC Qide VStar Capital Youshan Capital China Everbright Investment Management China Growth Capital | CGC CICC Qide VStar Capital Youshan Capital |
12/2021 | Series A | 5 | $120M |
Youshan Capital China Growth Capital CICC Qide Fund V Star Capital China Everbright Limited China Everbright Investment Management China Growth Capital | CGC CICC Qide VStar Capital Youshan Capital |
4/2021 | Seed | - |
Korea Investment Partners Cowin Capital Korea Investment Partners Cowin Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|